PAI-1 and D-dimer in type 2 diabetic women with asymptomatic macrovascular disease assessed by carotid Doppler

Clin Appl Thromb Hemost. 2010 Apr;16(2):204-8. doi: 10.1177/1076029609334626. Epub 2009 Oct 13.

Abstract

Asymptomatic diabetic patients with different degrees of macrovascular complications can present different hemostatic changes. At this study, plasminogen activator inhibitor-1 (PAI-1) and D-dimer were evaluated in 12 women without diabetes and 64 type 2 diabetic women. All patients were classified into 3 different categories according to the carotid intima-media thickness (IMT) assessed by Doppler: 25 with <1 mm (normal), 15 with >1 mm and without plaque (intermediate), and 24 with stenosis lower than 50% of the vessel lumen (plaque). The results showed increased plasma D-dimer in type 2 diabetic women with carotid plaque when compared to the other groups. High levels of PAI-1 were observed in all the 3 groups of diabetic women when compared to women without diabetes. Our results suggest that high levels of PAI-1 in type 2 diabetic women are only associated with diabetes and are not associated with macrovascular progression; however, it seems that D-dimer plasma levels are associated with carotid plaque.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • Carotid Artery Diseases / blood
  • Carotid Artery Diseases / diagnostic imaging*
  • Diabetic Angiopathies / blood
  • Diabetic Angiopathies / diagnostic imaging*
  • Disease Progression
  • Female
  • Fibrin Fibrinogen Degradation Products / analysis*
  • Fibrin Fibrinogen Degradation Products / chemistry
  • Glycosylation
  • Humans
  • Middle Aged
  • Plasminogen Activator Inhibitor 1 / analysis*
  • Thrombophilia / blood*
  • Thrombophilia / etiology
  • Ultrasonography, Doppler

Substances

  • Biomarkers
  • Fibrin Fibrinogen Degradation Products
  • Plasminogen Activator Inhibitor 1
  • SERPINE1 protein, human
  • fibrin fragment D